Minzhi Xing
Minzhi Xing
Yale School of Medicine, Johns Hopkins University
yale.edu üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict …
JC Camacho, N Kokabi, M Xing, HJ Prajapati, B El-Rayes, HS Kim
Journal of Vascular and Interventional Radiology 25 (2), 256-265, 2014
762014
Comparative effectiveness of thermal ablation, surgical resection, and active surveillance for T1a renal cell carcinoma: a Surveillance, Epidemiology, and End Results (SEER …
M Xing, N Kokabi, D Zhang, JM Ludwig, HS Kim
Radiology 288 (1), 81-90, 2018
562018
Survival, efficacy, and safety of small versus large doxorubicin drug-eluting beads TACE chemoembolization in patients with unresectable HCC
HJ Prajapati, M Xing, JR Spivey, SI Hanish, BF El-Rayes, JS Kauh, ...
American Journal of Roentgenology 203 (6), W706-W714, 2014
502014
RENAL (Radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines) nephrometry score predicts early tumor …
JC Camacho, N Kokabi, M Xing, VA Master, JG Pattaras, PK Mittal, ...
Journal of Vascular and Interventional Radiology 26 (5), 686-693, 2015
492015
Open‐label prospective study of the safety and efficacy of glass‐based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis
N Kokabi, JC Camacho, M Xing, BF El‐Rayes, JR Spivey, SJ Knechtle, ...
Cancer 121 (13), 2164-2174, 2015
462015
Selective internal yttrium-90 radioembolization therapy (90Y-SIRT) versus best supportive care in patients with unresectable metastatic melanoma to the liver refractory to …
M Xing, HJ Prajapati, R Dhanasekaran, DH Lawson, N Kokabi, BR Eaton, ...
American journal of clinical oncology 40 (1), 27-34, 2017
442017
A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study
N Kokabi, JR Galt, M Xing, JC Camacho, BJ Barron, DM Schuster, HS Kim
Journal of Vascular and Interventional Radiology 25 (2), 277-287, 2014
442014
Apparent diffusion coefficient quantification as an early imaging biomarker of response and predictor of survival following yttrium-90 radioembolization for unresectable …
N Kokabi, JC Camacho, M Xing, D Qiu, H Kitajima, PK Mittal, HS Kim
Abdominal imaging 39 (5), 969-978, 2014
422014
KRAS status as an independent prognostic factor for survival after yttrium-90 radioembolization therapy for unresectable colorectal cancer liver metastases
SJ Lahti, M Xing, D Zhang, JJ Lee, MJ Magnetta, HS Kim
Journal of vascular and interventional radiology 26 (8), 1102-1111, 2015
392015
Locoregional therapies for metastatic colorectal carcinoma to the liver—An evidence‐based review
M Xing, DA Kooby, BF El‐Rayes, N Kokabi, JC Camacho, HS Kim
Journal of surgical oncology 110 (2), 182-196, 2014
362014
Diagnostic utility of MRI and MR arthrography for detection of ligamentum teres tears: a retrospective analysis of 187 patients with hip pain
A Datir, M Xing, J Kang, P Harkey, A Kakarala, WA Carpenter, MR Terk
American Journal of Roentgenology 203 (2), 418-423, 2014
312014
Baseline and early MR apparent diffusion coefficient quantification as a predictor of response of unresectable hepatocellular carcinoma to doxorubicin drug-eluting bead …
N Kokabi, JM Ludwig, JC Camacho, M Xing, PK Mittal, HS Kim
Journal of Vascular and Interventional Radiology 26 (12), 1777-1786, 2015
282015
Covered stents and coil embolization for treatment of postpancreatectomy arterial hemorrhage
KC Ching, E Santos, KM McCluskey, PD Orons, R Bandi, CJ Friend, ...
Journal of Vascular and Interventional Radiology 27 (1), 73-79, 2016
272016
Preservation of quality of life with doxorubicin drug‐eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma: Longitudinal prospective study
M Xing, G Webber, HJ Prajapati, Z Chen, B El‐Rayes, JR Spivey, AA Pillai, ...
Journal of gastroenterology and hepatology 30 (7), 1167-1174, 2015
252015
90Y radioembolization lung shunt fraction in primary and metastatic liver cancer as a biomarker for survival
M Xing, S Lahti, N Kokabi, DM Schuster, JC Camacho, HS Kim
Clinical nuclear medicine 41 (1), 21-27, 2016
242016
Ablation versus resection for stage 1A renal cell carcinoma: national variation in clinical management and selected outcomes
J Uhlig, N Kokabi, M Xing, HS Kim
Radiology 288 (3), 889-897, 2018
232018
Radiographic evaluation of INBONE total ankle arthroplasty: a retrospective analysis of 30 cases
A Datir, M Xing, A Kakarala, MR Terk, SA Labib
Skeletal radiology 42 (12), 1693-1701, 2013
232013
Intra-abdominal solid organ injuries: an enhanced management algorithm
N Kokabi, W Shuaib, M Xing, E Harmouche, K Wilson, JO Johnson, ...
Canadian Association of Radiologists Journal 65 (4), 301-309, 2014
222014
Percutaneous management of benign biliary strictures with large-bore catheters: comparison between patients with and without orthotopic liver transplantation
JM Ludwig, GR Webber, SJ Knechtle, JR Spivey, M Xing, HS Kim
Journal of Vascular and Interventional Radiology 27 (2), 219-225. e1, 2016
202016
PET response criteria for solid tumors predict survival at three months after intra-arterial resin-based 90Yttrium radioembolization therapy for unresectable intrahepatic …
JC Camacho, N Kokabi, M Xing, DM Schuster, HS Kim
Clinical nuclear medicine 39 (11), 944-950, 2014
202014
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20